Long noncoding RNA Linc00460 promotes breast cancer progression by regulating the miR-489-5p/FGF7/AKT axis

References

• Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004;6(6):229–239.15535852
   PubMed Web of Science ®Google Scholar
• Karamouzis MV, Papavassiliou AG. Targeting insulin-like growth factor in breast cancer therapeutics. Crit Rev Oncol Hematol. 2012;84(1):8–17.22424863
   PubMed Web of Science ®Google Scholar
• Wood SL, Westbrook JA, Brown JE. Omic-profiling in breast cancer metastasis to bone: implications for mechanisms, biomarkers and treatment. Cancer Treat Rev. 2014;40(1):139–152.23958309
   PubMed Web of Science ®Google Scholar
• Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10:38.21489289
   PubMed Web of Science ®Google Scholar
• Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452–463.27070700
   PubMed Web of Science ®Google Scholar
• Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155–159.19188922
   PubMed Web of Science ®Google Scholar
• Carpenter S, Aiello D, Atianand MK, et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science. 2013;341(6147):789–792.23907535
   PubMed Web of Science ®Google Scholar
• Puvvula PK, Desetty RD, Pineau P, et al. Long noncoding RNA PANDA and scaffold-attachment-factor SAFA control senescence entry and exit. Nat Commun. 2014;5:5323.25406515
   PubMed Web of Science ®Google Scholar
• Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15(1):7–21.24296535
   PubMed Web of Science ®Google Scholar
• Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629–641.19239885
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tao Y, Liao Q. Long noncoding RNA: a crosslink in biological regulatory network. Brief Bioinform. 2017;19(5):930–945.
   Web of Science ®Google Scholar
• Carroll C, Jagatiya M. A rare case of a parapharyngeal schwannoma — an incidental finding. Int J Oral Maxillofac Surg. 2017;46:281.27769737
   PubMedGoogle Scholar
• Wang ZL, Li B, Piccolo SR, et al. Integrative analysis reveals clinical phenotypes and oncogenic potentials of long non-coding RNAs across 15 cancer types. Oncotarget. 2016;7(23):35044–35055.27147563
   PubMedGoogle Scholar
• Wang L, Li J, Zhao H, et al. Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes. Mol Biosyst. 2016;12(3):711–720.26725846
   PubMedGoogle Scholar
• Liang Y, Wu Y, Chen X, et al. A novel long noncoding RNA linc00460 up-regulated by CBP/P300 promotes carcinogenesis in esophageal squamous cell carcinoma. Biosci Rep. 2017;37(5): BSR20171019.
   Google Scholar
• Kong YG, Cui M, Chen SM, Xu Y, Xu Y, Tao ZZ. LncRNA-LINC00460 facilitates nasopharyngeal carcinoma tumorigenesis through sponging miR-149-5p to up-regulate IL6. Gene. 2018;639:77–84.28987345
   PubMed Web of Science ®Google Scholar
• Cao W, Liu JN, Liu Z, et al. A three-lncRNA signature derived from the atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma. Oral Oncol. 2017;65:94–101.28109476
   PubMed Web of Science ®Google Scholar
• Neve RM, Chin K, Fridlyand J, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006;10(6):515–527.17157791
   PubMed Web of Science ®Google Scholar
• Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003;30(3):256–268.12798140
   PubMed Web of Science ®Google Scholar
• Sankaran VG, Menne TF, Scepanovic D, et al. MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13. P Natl Acad Sci USA. 2011;108(4):1519–1524.
   PubMed Web of Science ®Google Scholar
• Sun LC, Song LB, Wan QF, et al. cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions. Cell Res. 2015;25(4):429–444.25793315
   PubMed Web of Science ®Google Scholar
• Zhang P, Cao L, Fan P, Mei Y, Wu M. LncRNA-MIF, a c-Myc-activated long non-coding RNA, suppresses glycolysis by promoting Fbxw7-mediated c-Myc degradation. EMBO Rep. 2016;17(8):1204–1220.27317567
   PubMed Web of Science ®Google Scholar
• Wang WX, Wilfred BR, Hu YL, Stromberg AJ, Nelson PT. Anti-Argonaute RIP-Chip shows that miRNA transfections alter global patterns of mRNA recruitment to microribonucleoprotein complexes. Rna. 2010;16(2):394–404.20042474
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen CY, Qian PX, et al. Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor. Nat Commun. 2015;6: 5988.
   PubMed Web of Science ®Google Scholar
• Qian P, Banerjee A, Wu ZS, et al. Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cells. Cancer Res. 2012;72(22):6036–6050.23019226
   PubMed Web of Science ®Google Scholar
• Su X, Xing J, Wang Z, Chen L, Cui M, Jiang B. microRNAs and ceRNAs: RNA networks in pathogenesis of cancer. Chin J Cancer Res. 2013;25(2):235–239.23592905
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233.19167326
   PubMed Web of Science ®Google Scholar
• Lei HP, Deng CX. Fibroblast growth factor receptor 2 signaling in breast cancer. Int J Biol Sci. 2017;13(9):1163–1171.29104507
   PubMed Web of Science ®Google Scholar
• Lyakhovich A, Aksenov N, Pennanen P, et al. Vitamin D induced up-regulation of keratinocyte growth factor (FGF-7/KGF) in MCF-7 human breast cancer cells. Biochem Bioph Res Co. 2000;273(2):675–680.
   PubMed Web of Science ®Google Scholar
• Turczyk L, Kitowska K, Mieszkowska M, et al. FGFR2-driven signaling counteracts tamoxifen Effect on ERalpha-positive breast cancer cells. Neoplasia. 2017;19(10):791–804.28869838
   PubMed Web of Science ®Google Scholar
• Zang XP, Siwak DR, Nguyen TX, Tari AM, Pento JT. KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2. Clin Exp Metastas. 2004;21(5):437–443.
   PubMed Web of Science ®Google Scholar
• Chai P, Tian J, Zhao D, et al. GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion. Biochem Biophys Res Commun. 2016;471(1):123–128.26828271
   PubMed Web of Science ®Google Scholar
• Gao S, Liu H, Hou S, et al. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer. Clin Transl Oncol. 2018; 20(6):703-712.
   Web of Science ®Google Scholar
• Li J, Qu W, Jiang Y, et al. miR-489 suppresses proliferation and invasion of human bladder cancer cells. Oncol Res. 2016;24(6):391–398.28281959
   PubMed Web of Science ®Google Scholar
• Liu Q, Yang G, Qian Y. Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway. Mol Carcinog. 2017;56(4):1312–1321.27859625
   PubMed Web of Science ®Google Scholar
• Yuan P, He XH, Rong YF, et al. KRAS/NF-kappaB/YY1/miR-489 signaling axis controls pancreatic cancer metastasis. Cancer Res. 2017;77(1):100–111.27793842
   PubMed Web of Science ®Google Scholar
• Huang TT, Wang L, Liu D, et al. FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1. Int J Oncol. 2017;50(5):1501–1512.28339036
   PubMed Web of Science ®Google Scholar
• Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov. 2009;8(3):235–253.19247306
   PubMed Web of Science ®Google Scholar
• Knights V, Cook SJ. De-regulated FGF receptors as therapeutic targets in cancer. Pharmacol Therapeut. 2010;125(1):105–117.
   PubMed Web of Science ®Google Scholar
• Grose R, Dickson C. Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth F R. 2005;16(2):179–186.
   PubMed Web of Science ®Google Scholar
• Kwabi-Addo B, Ozen M, Ittmann M. The role of fibroblast growth factors and their receptors in prostate cancer. Endocr-Relat Cancer. 2004;11(4):709–724.15613447
   PubMed Web of Science ®Google Scholar
• Yamayoshi T, Nagayasu T, Matsumoto K, Abo T, Hishikawa Y, Koji T. Expression of keratinocyte growth factor/fibroblast growth factor-7 and its receptor in human lung cancer: correlation with tumour proliferative activity and patient prognosis. J Pathol. 2004;204(1):110–118.15307144
   PubMed Web of Science ®Google Scholar
• Penaultllorca F, Bertucci F, Adelaide J, et al. Expression of Fgf and Fgf receptor genes in human breast-cancer. Int J Cancer. 1995;61(2):170–176.7705943
   PubMed Web of Science ®Google Scholar